Wednesday, December 6, 2023
No Result
View All Result
No Result
View All Result

Ironwood Pharmaceuticals (IRWD) Stock Forecast & Price Prediction

Estimation of the future price movement of Ironwood Pharmaceuticals stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $10.35

Concensus $16.00

Low $16.00

Median $16.00

High $16.00

Based on analysts projections #IRWD is expected to experience a positive growth trajectory over the next year.

The current average IRWD price target, as estimated by these analysts, is $16.00.

The predictions for the future IRWD stock price range from a low of $16.00 to a high of $16.00, highlighting the variability of market expectations for IRWD.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

IRWD stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
David Amsellem
Piper Sandler 		April 22, 2022 Buy 16.00 12.18

Ironwood Pharmaceuticals (IRWD) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Ironwood Pharmaceuticals is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Strong Buy

Financial Scores

Updated on: 06/12/2023

Altman Z-Score: -8.4

Piotroski Score: 3.0

ESG Score

Updated on: 06/12/2023

Environmental: 52.7

Social: 75.4

Governance: 76.7

Financial Health

Updated on: 06/12/2023

DCF: Strong Buy

ROE: Neutral

ROA: Neutral

Debt to equity ratio: Buy

Price to earnings ratio: Strong Buy

Price to book ratio: Strong Buy

IRWD Discounted Cash Flow

Updated on: 06/12/2023

$14.122
Discounted Cash Flow Value

$10.350
Current Price

IRWD Revenues by Segment

Updated on: 06/12/2023

Collaborative arrangement, co-promotion agreements
$21,940.00
Collaborative arrangement, collaboration and license agreements
$6,350.00
Collaborative arrangement, other agreements
$18,240.00
Collaborative arrangements revenue
$4,105,960.00

Revenue from Contract with Customer, Excluding Assessed Tax

IRWD Revenues by Region

Updated on: 06/12/2023

Europe and Other
$24,000.00
North America
$27,310.00
Canada and Mexico
$27,000.00

IRWD Notes Due

Updated on: 06/12/2023

CIKExchangeTitle

There are no data to display

Ironwood Pharmaceuticals (IRWD) Social Sentiments

Monitoring bullish and bearish sentiments towards Ironwood Pharmaceuticals on Twitter and Stocktwits could help to forecast an upward or downward trend in Ironwood Pharmaceuticals stock price.

Ironwood Pharmaceuticals Stock Forecast: Innovating and Expanding in the Gastrointestinal Drug Market

Ironwood Pharmaceuticals (IRWD) is a leading drug manufacturer specializing in developing medications for gastrointestinal disorders. IRWD operates in the Drug Manufacturers - Specialty & Generic sector of the pharmaceutical industry, and has developed a range of innovative drugs that treat conditions associated with the digestive system. With a strong focus on research and development, Ironwood Pharmaceuticals is continuously expanding its... Read more

Ironwood Pharmaceuticals: A Stock Prediction for the Drug Manufacturers - Specialty & Generic Sector

The Drug Manufacturers - Specialty & Generic stock market sector is a crucial part of the pharmaceutical industry. This sector comprises companies that manufacture specialty drugs and generic drugs. In this market, investors look to invest in pharmaceutical companies that produce innovative and high-quality drugs. One such company that has caught the attention of investors is Ironwood Pharmaceuticals, with stock... Read more
No Result
View All Result

© 2023 Best Stocks